Veeva Systems Inc. (NYSE:VEEV) Downgraded Amid Market Challenges

Font: Financial Modeling Prep  • Dec 11, 2025

• Veeva Systems Inc. (NYSE:VEEV) faces a downgrade by KeyBanc to a Sector Weight rating amidst a 22.8% decline over the past month.
• The stock's underperformance is highlighted against the Zacks S&P 500 composite's slight increase of 0.9%.
• Despite market downturns, Veeva's market capitalization of approximately $37.72 billion and active trading volume suggest continued investor interest.

Veeva Systems Inc. (NYSE:VEEV) is a prominent player in the cloud-based software industry, primarily serving the life sciences sector. The company provides solutions for customer relationship management, content management, and data analytics. Veeva's competitors include companies like Oracle and Salesforce, which also offer cloud-based solutions for various industries.

On December 11, 2025, KeyBanc downgraded Veeva Systems to a Sector Weight rating, with the stock priced at $229.47. This downgrade comes amid a challenging period for Veeva, as its shares have declined by 22.8% over the past month. This decline contrasts with the Zacks S&P 500 composite's slight increase of 0.9%, highlighting the stock's underperformance.

The Zacks Medical Info Systems industry, which includes Veeva, has also faced a downturn, with a loss of 9.3% during the same period. Despite this, Veeva remains a trending stock on Zacks.com, indicating continued interest from investors. The stock's current price of $229.47 reflects a slight increase of 0.31, or 0.14%, with fluctuations between $227.34 and $231.34 during the trading day.

Veeva's market capitalization stands at approximately $37.72 billion, showcasing its significant presence in the industry. The stock has experienced a 52-week high of $310.50 and a low of $201.54, indicating considerable volatility. Today's trading volume for VEEV is 1,521,286 shares, suggesting active investor engagement despite recent challenges.

While media reports or rumors can influence short-term stock price changes, fundamental factors like earnings estimate revisions are crucial for long-term investment decisions. Investors should consider these elements when evaluating Veeva's future prospects, especially in light of the recent downgrade and market performance.